Ashok Leyland shares surge 6% after posting 20% YoY increase in Q4 profit. Should you invest?

Ashok Leyland shares surged nearly 6% on BSE to a record high after reporting a 20% YoY increase in its Q4 net profit.

shares zoomed nearly 6% on BSE today to their new all-time high of Rs 222.80 after reporting a 20% year-on-year (YoY) in its Q4 net at Rs 900.41 crore.

from in the quarter under review stood at Rs 11,266.69 crore as compared to Rs 11,625.67 crore in the year-ago period.

Here’s how view the Q4 :



Demand momentum in the domestic market continues to remain healthy led by pick-up in replacement demand. The company reiterated its focus on profitable growth. Medium-term demand drivers (higher infra spends, scrappage policy, etc.) remain intact and AL aims for higher share in MHCVs (to c.35%) and LCV led by network expansion and addressing product gaps.

maintained a 'buy' rating on stock with a target price of Rs 275.



Motilal expects a recovery in CV demand from 2HFY25 onwards as structural demand drivers remain intact. The company is the best choice in the CV growth cycle, as it has positioned itself to expand revenue/profit pools. Moreover, its focus on profitable growth driven by lower discounts, a better mix, and cost control measures should bode well for EBITDA margin expansion over FY24-26E.

The brokerage firm raised its FY25E/FY26E EPS by 7%/6% to factor in a better gross margin and a lower interest burden.

They have a 'buy' call on the stock with a target price of Rs 245.

Also read:




KIE expects CV industry volumes to recover post elections, especially driven by the buses segment. Also, they expect profitability of the company to be maintained at current levels in FY2025E driven by increase in non-auto mix and cost-control measures.

Kotak has a 'reduce' rating on the stock with a target price of Rs 200.



ICICI Securities is expecting overall switch mobility to remain EBITDA positive in FY25 aided by India business' strong pipeline. ICICI Securities has built in flat volumes for the domestic M&HCV goods industry in FY25E, before a 10% dip in FY26E, thus factoring in AL’s M&HCV volume CAGR at 6% over FY24-26E, assuming steady market share.

ICICI Securities has a 'sell' view on the stock with a target price of Rs 140.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?